Expert Opinion on Biological Therapy, Volume 23, Issue 4 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 23, Issue 4 (2023)

See all volumes and issues
Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Isatuximab in multiple myeloma
Enrica Antonia Martino, Antonella Bruzzese, Enrico Iaccino, Francesco Mendicino, Selena Mimmi, Eugenio Lucia, Virginia Olivito, Antonino Neri, Fortunato Morabito, Ernesto Vigna & Massimo Gentile
Pages: 315-318
Published online: 24 Mar 2023
First Page PreviewforIsatuximab in multiple myeloma | Full Text | References | PDF (715.9 KB) | EPUB
  • 1538 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Advances in the development of tumor-infiltrating lymphocyte therapy for advanced melanoma
Max Julve & Andrew JS Furness
Pages: 319-323
Published online: 27 Apr 2023
First Page PreviewforAdvances in the development of tumor-infiltrating lymphocyte therapy for advanced melanoma | Full Text | References | PDF (704.9 KB) | EPUB
  • 1695 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Advances in biological and targeted therapies for systemic sclerosis
Erica Mulcaire-Jones, Andrea Hsiu Ling Low, Robyn Domsic, Michael L Whitfield & Dinesh Khanna
Pages: 325-339
Published online: 26 Apr 2023
AbstractforAdvances in biological and targeted therapies for systemic sclerosis | Full Text | References | PDF (725.8 KB) | EPUB
  • 589 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?
Suzanne I. Anjie, Melanie S. Hulshoff & Geert D’Haens
Pages: 341-351
Published online: 09 Apr 2023
AbstractforEfficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand? | Full Text | References | PDF (329.5 KB) | EPUB
  • 345 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Ex vivo gene therapy for lysosomal storage disorders: future perspectives
Edina Poletto, Andrew Oliveira Silva, Ricardo Weinlich, Priscila Keiko Matsumoto Martin, Davi Coe Torres, Roberto Giugliani & Guilherme Baldo
Pages: 353-364
Published online: 20 Mar 2023
AbstractforEx vivo gene therapy for lysosomal storage disorders: future perspectives | Full Text | References | PDF (1.5 MB) | EPUB
  • 163 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study
Giacomo Caldarola, A Chiricozzi, M Megna, P Dapavo, A Giunta, M Burlando, P Malagoli, V Dini, M Mariani, G Fabbrocini, P Quaglino, L Bianchi, A Parodi, K Peris & C De Simone
Pages: 365-370
Published online: 20 Mar 2023
AbstractforReal-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study | Full Text | References | PDF (272.2 KB) | EPUB
  • 417 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks
Marco Galluzzo, Lorenzo Marcelli, Laura Vellucci, Claudia Paganini, Virginia Maffei, Lorenzo Tofani, Alfredo Belcastro, Luca Bianchi & Marina Talamonti
Pages: 371-381
Published online: 27 Mar 2023
AbstractforGuselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks | Full Text | References | PDF (6.2 MB) | EPUB
  • 1915 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Correction

Correction
Correction
Pages: i-iv
Published online: 06 Mar 2023
First Page PreviewforCorrection | Full Text | PDF (210 KB) | EPUB
  • 218 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles